Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Biochimica Et Biophysica Acta|January 11, 2011
A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serumFrancesca Lavatelli, Francesca Brambilla, Veronica Valentini, et al.The FEBS Journal|September 5, 2021
Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregationGiulia Mazzini, Stefano Ricagno, Serena Caminito, et al.Worm|October 3, 2015
Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegansLuisa Diomede, Paola Rognoni, Francesca Lavatelli, et al.Clinical Chemistry and Laboratory Medicine|March 5, 2016
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosisGiovanni Palladini, Paolo Milani, Andrea Foli, et al.Matrix Biology : Journal of the International Society for Matrix Biology|July 16, 2025
Role of extracellular space and matrix remodeling in cardiac amyloidosisFrancesca Lavatelli, Loredana Marchese, Palma Patrizia Mangione, et al.Protein Science : a Publication of the Protein Society|February 21, 2024
Degradation versus fibrillogenesis, two alternative pathways modulated by seeds and glycosaminoglycansGuglielmo Verona, Sara Raimondi, Diana Canetti, et al.Blood|January 26, 2006
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in ALGiovanni Palladini, Francesca Lavatelli, Paola Russo, et al.Clinical Lymphoma & Myeloma|April 14, 2009
AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entityGiovanni Palladini, Paola Russo, Tiziana Bosoni, et al.Blood|February 1, 2015
A practical approach to the diagnosis of systemic amyloidosesCarlos Fernández de Larrea, Laura Verga, Patrizia Morbini, et al.JPEN. Journal of Parenteral and Enteral Nutrition|September 28, 2013
Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatmentRiccardo Caccialanza, Giovanni Palladini, Catherine Klersy, et al.Pageof 7